HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.

Abstract
To test the potential of a multigene DNA vaccine against lentivirus infection, we generated a defective mutant provirus of feline immunodeficiency virus (FIV) with an in-frame deletion in pol (FIVDeltaRT). In a first experiment, FIVDeltaRT DNA was administered intramuscularly to 10 animals, half of which also received feline gamma interferon (IFN-gamma) DNA. The DNA was administered in four 100-microg doses at 0, 10, and 23 weeks. Immunization with FIVDeltaRT elicited cytotoxic T-cell (CTL) responses to FIV Gag and Env in the absence of a serological response. After challenge with homologous virus at week 26, all 10 of the control animals became seropositive and viremic but 4 of the 10 vaccinates remained seronegative and virus free. Furthermore, quantitative virus isolation and quantitative PCR analysis of viral DNA in peripheral blood mononuclear cells revealed significantly lower virus loads in the FIVDeltaRT vaccinates than in the controls. Immunization with FIVDeltaRT in conjunction with IFN-gamma gave the highest proportion of protected cats, with only two of five vaccinates showing evidence of infection following challenge. In a second experiment involving two groups (FIVDeltaRT plus IFN-gamma and IFN-gamma alone), the immunization schedule was reduced to 0, 4, and 8 weeks. Once again, CTL responses were seen prior to challenge in the absence of detectable antibodies. Two of five cats receiving the proviral DNA vaccine were protected against infection, with an overall reduction in virus load compared to the five infected controls. These findings demonstrate that DNA vaccination can elicit protection against lentivirus infection in the absence of a serological response and suggest the need to reconsider efficacy criteria for lentivirus vaccines.
AuthorsM J Hosie, J N Flynn, M A Rigby, C Cannon, T Dunsford, N A Mackay, D Argyle, B J Willett, T Miyazawa, D E Onions, O Jarrett, J C Neil
JournalJournal of virology (J Virol) Vol. 72 Issue 9 Pg. 7310-9 (Sep 1998) ISSN: 0022-538X [Print] United States
PMID9696827 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • DNA, Viral
  • Vaccines, DNA
  • Viral Vaccines
Topics
  • Amino Acid Sequence
  • Animals
  • Antibodies, Viral (blood)
  • Base Sequence
  • Cats
  • Cell Line
  • DNA, Viral (blood)
  • Drug Administration Schedule
  • Humans
  • Immunodeficiency Virus, Feline (immunology, physiology)
  • Lentivirus Infections (prevention & control)
  • Molecular Sequence Data
  • Proviruses (genetics)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Vaccination
  • Vaccines, DNA (immunology)
  • Viral Load
  • Viral Vaccines (immunology)
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: